-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Maintains Buy on Conmed, Raises Price Target to $75

Benzinga·02/06/2025 16:58:55
Listen to the news
Stifel analyst Rick Wise maintains Conmed (NYSE:CNMD) with a Buy and raises the price target from $72 to $75.